Literature DB >> 28160607

Overlap between irritable bowel syndrome and functional dyspepsia including subtype analyses.

Yoon Jin Choi1, Nayoung Kim1,2, Hyuk Yoon1, Cheol Min Shin1, Young Soo Park1,2, Jin-Wook Kim1,2, Yong Sung Kim3, Dong Ho Lee1,2, Hyun Chae Jung2.   

Abstract

BACKGROUND AND AIM: Coexistent gastrointestinal symptom profiles and prevalence or associated factors for the overlap between each functional dyspepsia (FD) and irritable bowel syndrome (IBS) group remain unclear. Thus, the aim of the present study was to evaluate the clinicodemographic features of FD, IBS, and IBS-FD overlap and assess the risk factors thereof, including subtype and genetic polymorphisms for IBS-FD.
METHODS: Consecutive patients were enrolled from the outpatient Gastroenterology clinics of Bundang Seoul National University Hospitals in Korea. All gastrointestinal symptoms occurring at least once per week in the previous 3 months were recorded. Diagnostic criteria of functional gastrointestinal disorders were based on the Rome III criteria. Risk factors including genetic polymorphisms of 5-HTTLPR and ADRA2A 1291 G alleles and CCK-1R intron 779T>C were assessed using a multivariate logistic regression model.
RESULTS: A total of 632 subjects (278 control subjects, 308 FD, 156 IBS, and 110 who met the criteria for both FD and IBS) were included in this study. Patients with IBS-FD overlap had more severe symptoms (such as bloating, nausea, vomiting, hard or lumpy stools, defecation straining, and a feeling of incomplete bowel movement) and higher depression scores compared with non-overlap patients. Single/divorced or widowed marital status, nausea, bloating, and a feeling of incomplete emptying after bowel movements were independent risk factors for IBS-FD overlap among IBS patients. In contrast, young age, depression, bloating, and postprandial distress syndrome were positively associated with IBS-FD overlap among FD patients. 5-HTTLPR L/L was a risk factor for the co-occurrence of IBS-C among FD patients (OR: 12.47; 95% CI: 2.00-77.75; P = 0.007).
CONCLUSIONS: Bloating was a risk factor for IBS-FD overlap. Patients with postprandial distress syndrome have a higher risk of coexisting IBS, particularly constipation-dominant IBS.
© 2017 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  bloating; depression; functional dyspepsia; irritable bowel syndrome

Mesh:

Substances:

Year:  2017        PMID: 28160607     DOI: 10.1111/jgh.13756

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  20 in total

1.  The challenges of evolving Rome criteria for functional dyspepsia.

Authors:  Craig A Friesen; Jennifer V Schurman
Journal:  Transl Gastroenterol Hepatol       Date:  2018-09-14

Review 2.  Use of Evidence-Based Herbal Medicines for Patients with Functional Gastrointestinal Disorders: A Conceptional Framework for Risk-Benefit Assessment and Regulatory Approaches.

Authors:  Gerald Holtmann; Dietmar Schrenk; Ahmed Madisch; Hans D Allescher; Gudrun Ulrich-Merzenich; Fermin Mearin; Dominique Larrey; Peter Malfertheiner
Journal:  Dig Dis       Date:  2019-11-26       Impact factor: 2.404

3.  Functional Disease, Dysbiosis, and Dyspepsia: How Helpful Is Rifaximin?

Authors:  Sridhar Sundaram; Harish Darak
Journal:  Dig Dis Sci       Date:  2021-08-14       Impact factor: 3.487

4.  Eating Behavior in Functional Dyspepsia.

Authors:  Younghee Choe; Kyung Ho Song
Journal:  J Neurogastroenterol Motil       Date:  2022-07-30       Impact factor: 4.725

5.  The Risk of Osteoporosis and Osteoporotic Fracture Following the Use of Irritable Bowel Syndrome Medical Treatment: An Analysis Using the OMOP CDM Database.

Authors:  Gyu Lee Kim; Yu Hyeon Yi; Hye Rim Hwang; Jinmi Kim; Youngmin Park; Yun Jin Kim; Jeong Gyu Lee; Young Jin Tak; Seung Hun Lee; Sang Yeoup Lee; Youn Hye Cho; Eun Ju Park; Youngin Lee
Journal:  J Clin Med       Date:  2021-05-10       Impact factor: 4.241

6.  Probiotics reduce repeated water avoidance stress-induced colonic microinflammation in Wistar rats in a sex-specific manner.

Authors:  Ju Yup Lee; Nayoung Kim; Ryoung Hee Nam; Sung Hwa Sohn; Sun Min Lee; Daeun Choi; Hyuk Yoon; Yong Sung Kim; Hye Seung Lee; Dong Ho Lee
Journal:  PLoS One       Date:  2017-12-15       Impact factor: 3.240

Review 7.  Pros and Cons While Looking Through an Asian Window on the Rome IV Criteria for Irritable Bowel Syndrome: Pros.

Authors:  Uday C Ghoshal
Journal:  J Neurogastroenterol Motil       Date:  2017-07-30       Impact factor: 4.924

8.  Classification of pediatric functional gastrointestinal disorders related to abdominal pain using Rome III vs. Rome IV criterions.

Authors:  Trent Edwards; Craig Friesen; Jennifer V Schurman
Journal:  BMC Gastroenterol       Date:  2018-03-17       Impact factor: 3.067

9.  Could Improvement in Subjective Well-being Relieve Gastrointestinal Symptoms in Patients With Irritable Bowel Syndrome?

Authors:  Seung-Ho Jang; Yong Sung Kim
Journal:  J Neurogastroenterol Motil       Date:  2018-04-30       Impact factor: 4.924

10.  Patients with Multiple Functional Gastrointestinal Disorders (FGIDs) Show Increased Illness Severity: A Cross-Sectional Study in a Tertiary Care FGID Specialty Clinic.

Authors:  Sabrina Berens; Felicitas Engel; Annika Gauss; Jonas Tesarz; Wolfgang Herzog; Beate Niesler; Esther Stroe-Kunold; Rainer Schaefert
Journal:  Gastroenterol Res Pract       Date:  2020-01-28       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.